These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 28265699)

  • 1. Continuous Manufacturing of Recombinant Therapeutic Proteins: Upstream and Downstream Technologies.
    Patil R; Walther J
    Adv Biochem Eng Biotechnol; 2018; 165():277-322. PubMed ID: 28265699
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrated continuous production of recombinant therapeutic proteins.
    Warikoo V; Godawat R; Brower K; Jain S; Cummings D; Simons E; Johnson T; Walther J; Yu M; Wright B; McLarty J; Karey KP; Hwang C; Zhou W; Riske F; Konstantinov K
    Biotechnol Bioeng; 2012 Dec; 109(12):3018-29. PubMed ID: 22729761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The business impact of an integrated continuous biomanufacturing platform for recombinant protein production.
    Walther J; Godawat R; Hwang C; Abe Y; Sinclair A; Konstantinov K
    J Biotechnol; 2015 Nov; 213():3-12. PubMed ID: 26014522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Current Scientific and Regulatory Landscape in Advancing Integrated Continuous Biopharmaceutical Manufacturing.
    Fisher AC; Kamga MH; Agarabi C; Brorson K; Lee SL; Yoon S
    Trends Biotechnol; 2019 Mar; 37(3):253-267. PubMed ID: 30241924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GMP implementation of a hybrid continuous manufacturing process for a recombinant non-mAb protein-A case study.
    Natarajan V; Soice N; Mullen J; Bull D
    Biotechnol Prog; 2024; 40(4):e3459. PubMed ID: 38553839
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A modular and multi-functional purification strategy that enables a common framework for manufacturing scale integrated and continuous biomanufacturing.
    Pybus LP; Heise C; Nagy T; Heeran C; Dover T; Raven J; Kori J; Burton G; Sakuyama H; Hastings B; Lyons M; Nakai S; Haigh J
    Biotechnol Prog; 2024; 40(4):e3456. PubMed ID: 38494903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Continuous downstream processing for high value biological products: A Review.
    Zydney AL
    Biotechnol Bioeng; 2016 Mar; 113(3):465-75. PubMed ID: 26153056
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biomanufacturing evolution from conventional to intensified processes for productivity improvement: a case study.
    Xu J; Xu X; Huang C; Angelo J; Oliveira CL; Xu M; Xu X; Temel D; Ding J; Ghose S; Borys MC; Li ZJ
    MAbs; 2020 Jan; 12(1):1770669. PubMed ID: 32425110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A new large-scale manufacturing platform for complex biopharmaceuticals.
    Vogel JH; Nguyen H; Giovannini R; Ignowski J; Garger S; Salgotra A; Tom J
    Biotechnol Bioeng; 2012 Dec; 109(12):3049-58. PubMed ID: 22688835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perfusion mammalian cell culture for recombinant protein manufacturing - A critical review.
    Bielser JM; Wolf M; Souquet J; Broly H; Morbidelli M
    Biotechnol Adv; 2018; 36(4):1328-1340. PubMed ID: 29738813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progression of continuous downstream processing of monoclonal antibodies: Current trends and challenges.
    Somasundaram B; Pleitt K; Shave E; Baker K; Lua LHL
    Biotechnol Bioeng; 2018 Dec; 115(12):2893-2907. PubMed ID: 30080940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enablers of continuous processing of biotherapeutic products.
    Rathore AS; Zydney AL; Anupa A; Nikita S; Gangwar N
    Trends Biotechnol; 2022 Jul; 40(7):804-815. PubMed ID: 35034769
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Continuous biomanufacturing with microbes - upstream progresses and challenges.
    Xie D
    Curr Opin Biotechnol; 2022 Dec; 78():102793. PubMed ID: 36088736
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of surge tanks for continuous manufacturing of monoclonal antibodies.
    Thakur G; Nikita S; Tiwari A; Rathore AS
    Biotechnol Bioeng; 2021 May; 118(5):1913-1931. PubMed ID: 33547800
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pilot-scale demonstration of an end-to-end integrated and continuous biomanufacturing process.
    Coolbaugh MJ; Varner CT; Vetter TA; Davenport EK; Bouchard B; Fiadeiro M; Tugcu N; Walther J; Patil R; Brower K
    Biotechnol Bioeng; 2021 Sep; 118(9):3287-3301. PubMed ID: 33410159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reviewing the process intensification landscape through the introduction of a novel, multitiered classification for downstream processing.
    Crowley L; Cashen P; Noverraz M; Lobedann M; Nestola P
    Biotechnol Bioeng; 2024 Mar; 121(3):877-893. PubMed ID: 38214109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Continuous processing for production of biopharmaceuticals.
    Rathore AS; Agarwal H; Sharma AK; Pathak M; Muthukumar S
    Prep Biochem Biotechnol; 2015; 45(8):836-49. PubMed ID: 25674930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Process intensification for the continuous production of an antimicrobial peptide in stably-transformed Sf-9 insect cells.
    Käßer L; Rotter M; Coletta L; Salzig D; Czermak P
    Sci Rep; 2022 Jan; 12(1):1086. PubMed ID: 35058492
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Process design of a fully integrated continuous biopharmaceutical process using economic and ecological impact assessment.
    Ding C; Ardeshna H; Gillespie C; Ierapetritou M
    Biotechnol Bioeng; 2022 Dec; 119(12):3567-3583. PubMed ID: 36109341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process-wide control and automation of an integrated continuous manufacturing platform for antibodies.
    Feidl F; Vogg S; Wolf M; Podobnik M; Ruggeri C; Ulmer N; Wälchli R; Souquet J; Broly H; Butté A; Morbidelli M
    Biotechnol Bioeng; 2020 May; 117(5):1367-1380. PubMed ID: 32022243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.